BIA-ALCL Class Actions
Nationwide Medical Product Liability Attorneys – (909) 345-8110
The Food and Drug Administration (FDA) recently notified healthcare providers of a concerning link between breast implants and anaplastic large cell lymphoma. Regardless of the filling, texture, or manufacturer of a breast implant, women with breast implants have an increased risk of developing the disease, which is officially called breast implant associated-anaplastic large cell lymphoma, or BIA-ALCL.
If you have been suffering from pain, swelling, or lumps around your breast implants, please speak with your medical provider for a diagnosis. If you have already been diagnosed with BIA-ALCL, and you were not adequately warned of such a risk from getting a breast implant, then you may be eligible to seek compensation. McCune Wright Arevalo, LLP is currently hearing from clients across the United States who may have a BIA-ALCL lawsuit.
You could be owed compensation if you have been diagnosed with BIA-ALCL. Learn more by contacting our medical product liability attorneys today.
FDA’s Findings On BIA-ALCL
As early as 2011, the FDA had suspicions that all breast implants, but especially textured implants, could increase the risk of this rare form of lymphoma. When a breast implant is surgically implanted, fibrous scar tissue will eventually envelop the implant. It is within this scar tissue that BIA-ALCL begins to develop.
The FDA has stated that there are:
- 660 medical device reports (MDR) about BIA-ALCL;
- 467 confirmed unique BIA-ALCL MDRs; and
- 9 reports of BIA-ALCL fatalities in patients.
With roughly 1.5 million patients receiving new breast implants across the world each year, the FDA has a genuine concern that the incidents of BIA-ALCL will continue to spike in upcoming years, especially as the disease is better understood. The FDA’s recent letter to medical providers, surgeons, and other physicians recommended full disclosure of information and risks to a patient about BIA-ALCL should occur before any breast implant surgery. It was also recommended that physicians conduct immediate testing of breast implant scar tissue to rule out or confirm BIA-ALCL.
Filing a BIA-ALCL Lawsuit With Our Help
There have already been lawsuits filed against breast implant manufacturers related to breast implant associated-anaplastic large cell lymphoma diagnoses. Most of the lawsuits seek compensation for medical costs associated with treatment and the initial implantation of the breast implants, wages lost due to illness, and noneconomic damages, such as pain, suffering, and emotional trauma.
It might be possible to hold a breast implant manufacturer liable due to:
- Inherently defective product design;
- Failure to warn physicians and patients of dangers; and/or
- Failure to thoroughly conduct product testing.
Depending on how further BIA-ALCL research pans out, and how many lawsuits come forward in the coming months, it is possible one or several class actions may be created. McCune Wright Arevalo, LLP and our medical product liability lawyers can help you understand your rights and legal options if you were diagnosed with BIA-ALCL after a breast implantation procedure. Keep in mind that symptoms may first be noticeable many years after breast implant surgery is completed. Our reputation for taking on major corporations — like Bayer, DePuy, Johnson & Johnson, Volkswagen, Wells Fargo, and many more — and winning precedes us. See what our caliber of legal service can do for you today.
Call (909) 345-8110 to arrange a free consultation with one of our lawyers.